577 related articles for article (PubMed ID: 33952281)
1. Reduction in pericyte coverage leads to blood-brain barrier dysfunction via endothelial transcytosis following chronic cerebral hypoperfusion.
Sun Z; Gao C; Gao D; Sun R; Li W; Wang F; Wang Y; Cao H; Zhou G; Zhang J; Shang J
Fluids Barriers CNS; 2021 May; 18(1):21. PubMed ID: 33952281
[TBL] [Abstract][Full Text] [Related]
2. C-kit controls blood-brain barrier permeability by regulating caveolae-mediated transcytosis after chronic cerebral hypoperfusion.
Shang J; Li W; Zhang H; Wang W; Liu N; Gao D; Wang F; Yan X; Gao C; Sun R; Zhang H; Ma K; Shao F; Zhang J
Biomed Pharmacother; 2024 Jan; 170():115778. PubMed ID: 38141279
[TBL] [Abstract][Full Text] [Related]
3. Protection of blood-brain barrier as a potential mechanism for enriched environments to improve cognitive impairment caused by chronic cerebral hypoperfusion.
Qu C; Xu L; Shen J; Li Y; Qu C; Song H; Zhang J
Behav Brain Res; 2020 Feb; 379():112385. PubMed ID: 31778736
[TBL] [Abstract][Full Text] [Related]
4. Experimental chronic cerebral hypoperfusion results in decreased pericyte coverage and increased blood-brain barrier permeability in the corpus callosum.
Liu Q; Radwanski R; Babadjouni R; Patel A; Hodis DM; Baumbacher P; Zhao Z; Zlokovic B; Mack WJ
J Cereb Blood Flow Metab; 2019 Feb; 39(2):240-250. PubMed ID: 29192539
[TBL] [Abstract][Full Text] [Related]
5. Impairment of pericyte-endothelium crosstalk leads to blood-brain barrier dysfunction following traumatic brain injury.
Bhowmick S; D'Mello V; Caruso D; Wallerstein A; Abdul-Muneer PM
Exp Neurol; 2019 Jul; 317():260-270. PubMed ID: 30926390
[TBL] [Abstract][Full Text] [Related]
6. Pericyte Dysfunction Contributes to Vascular Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats.
Lin S; Landon B; Zhang H; Jin K
Aging Dis; 2024 May; 15(3):1357-1372. PubMed ID: 37611900
[TBL] [Abstract][Full Text] [Related]
7. Mfsd2a Reverses Spatial Learning and Memory Impairment Caused by Chronic Cerebral Hypoperfusion via Protection of the Blood-Brain Barrier.
Qu C; Song H; Shen J; Xu L; Li Y; Qu C; Li T; Zhang J
Front Neurosci; 2020; 14():461. PubMed ID: 32612494
[TBL] [Abstract][Full Text] [Related]
8. The ameliorative effects of exercise on cognitive impairment and white matter injury from blood-brain barrier disruption induced by chronic cerebral hypoperfusion in adolescent rats.
Lee JM; Park JM; Song MK; Oh YJ; Kim CJ; Kim YJ
Neurosci Lett; 2017 Jan; 638():83-89. PubMed ID: 27956237
[TBL] [Abstract][Full Text] [Related]
9. Loss of Regulator of G-Protein Signaling 5 Leads to Neurovascular Protection in Stroke.
Özen I; Roth M; Barbariga M; Gaceb A; Deierborg T; Genové G; Paul G
Stroke; 2018 Sep; 49(9):2182-2190. PubMed ID: 30354999
[TBL] [Abstract][Full Text] [Related]
10. Neddylation in the chronically hypoperfused corpus callosum: MLN4924 reduces blood-brain barrier injury via ERK5/KLF2 signaling.
Yang X; Chang L; Liu Z; Geng X; Wang R; Yin X; Fan W; Zhao BQ
Exp Neurol; 2024 Jan; 371():114587. PubMed ID: 37914067
[TBL] [Abstract][Full Text] [Related]
11. PDGFR-β restores blood-brain barrier functions in a mouse model of focal cerebral ischemia.
Shen J; Xu G; Zhu R; Yuan J; Ishii Y; Hamashima T; Matsushima T; Yamamoto S; Takatsuru Y; Nabekura J; Sasahara M
J Cereb Blood Flow Metab; 2019 Aug; 39(8):1501-1515. PubMed ID: 29629621
[TBL] [Abstract][Full Text] [Related]
12. Reduced pericyte and tight junction coverage in old diabetic rats are associated with hyperglycemia-induced cerebrovascular pericyte dysfunction.
Liu Y; Zhang H; Wang S; Guo Y; Fang X; Zheng B; Gao W; Yu H; Chen Z; Roman RJ; Fan F
Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H549-H562. PubMed ID: 33306445
[TBL] [Abstract][Full Text] [Related]
13. Maresin 1 improves cognitive decline and ameliorates inflammation and blood-brain barrier damage in rats with chronic cerebral hypoperfusion.
Li T; Zheng J; Wang Z; Xu L; Sun D; Song H; Wu S; Du M; Peng S; Zhang J
Brain Res; 2022 Aug; 1788():147936. PubMed ID: 35533741
[TBL] [Abstract][Full Text] [Related]
14. Changes in blood-brain barrier permeability and ultrastructure, and protein expression in a rat model of cerebral hypoperfusion.
Sekaran H; Gan CY; A Latiff A; Harvey TM; Mohd Nazri L; Hanapi NA; Azizi J; Yusof SR
Brain Res Bull; 2019 Oct; 152():63-73. PubMed ID: 31301381
[TBL] [Abstract][Full Text] [Related]
15. Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion.
Edrissi H; Schock SC; Cadonic R; Hakim AM; Thompson CS
Brain Res; 2016 Sep; 1646():494-503. PubMed ID: 27350079
[TBL] [Abstract][Full Text] [Related]
16. Increased Expression of VCAM1 on Brain Endothelial Cells Drives Blood-Brain Barrier Impairment Following Chronic Cerebral Hypoperfusion.
Zhang H; Shang J; Li W; Gao D; Zhang J
ACS Chem Neurosci; 2024 May; 15(10):2028-2041. PubMed ID: 38710594
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-149-5p regulates blood-brain barrier permeability after transient middle cerebral artery occlusion in rats by targeting S1PR2 of pericytes.
Wan Y; Jin HJ; Zhu YY; Fang Z; Mao L; He Q; Xia YP; Li M; Li Y; Chen X; Hu B
FASEB J; 2018 Jun; 32(6):3133-3148. PubMed ID: 29401609
[TBL] [Abstract][Full Text] [Related]
18. Glycocalyx is critical for blood-brain barrier integrity by suppressing caveolin1-dependent endothelial transcytosis following ischemic stroke.
Zhu J; Li Z; Ji Z; Wu Y; He Y; Liu K; Chang Y; Peng Y; Lin Z; Wang S; Wang D; Huang K; Pan S
Brain Pathol; 2022 Jan; 32(1):e13006. PubMed ID: 34286899
[TBL] [Abstract][Full Text] [Related]
19. Single-Cell Analysis of Blood-Brain Barrier Response to Pericyte Loss.
Mäe MA; He L; Nordling S; Vazquez-Liebanas E; Nahar K; Jung B; Li X; Tan BC; Chin Foo J; Cazenave-Gassiot A; Wenk MR; Zarb Y; Lavina B; Quaggin SE; Jeansson M; Gu C; Silver DL; Vanlandewijck M; Butcher EC; Keller A; Betsholtz C
Circ Res; 2021 Feb; 128(4):e46-e62. PubMed ID: 33375813
[TBL] [Abstract][Full Text] [Related]
20. Disruption of Bmal1 Impairs Blood-Brain Barrier Integrity via Pericyte Dysfunction.
Nakazato R; Kawabe K; Yamada D; Ikeno S; Mieda M; Shimba S; Hinoi E; Yoneda Y; Takarada T
J Neurosci; 2017 Oct; 37(42):10052-10062. PubMed ID: 28912161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
